Carnelian Shift

Carnelian PMS | Equity | | PMS

IME's View on Carnelian Shift

Strategy

Focused on - Manufacturing & Technology Sector

Investment Fund

Carnelian Shift is a strategy aimed at identifying investment opportunities in manufacturing and technology. While Carnelian is a relatively young AMC, they are backed by experienced finance professionals albeit ones that lack a public track record of fund management and a good start to performance in the PMS.

Fund's Strategy View

Carnelian Shift is a long-only Mid & small-cap strategy, focused on investing in 2 key themes - manufacturing & technology. The focus is on mid & small-cap companies with existing core competencies, strong BS, governance and returns ratios.

Fund Performance

The fund has outperformed peers & is amongst the top performing schemes in this category in the last 5 year trailing returns.

IME's View on Carnelian PMS

View on AMC

Carnelian is a young firm in the Indian alternatives space with an impressive founding team from ex-senior investment team members of Edelweiss Securities. Vikas Khemani, the ex-CEO, and Manoj, the head of research, have strong research and investment business-building pedigrees. The investment philosophy and processes are well defined, combining quality growth investing (QGARP) with deep forensic diligence and thematic insights. Performance has been strong.

AMC's Pedigree

The firm is fully founder-owned and led by seasoned capital market professionals with backgrounds in institutional equities, forensic research, and business leadership.

AMC Team

Carnelian is founded by seasoned capital markets professionals with deep institutional experience. Vikas Khemani, former CEO of Edelweiss Securities, brings strategic leadership and decades of market insight. Manoj Bahety, a pioneer in forensic research, developed the acclaimed “Analysis Beyond Consensus” framework. Swati Khemani adds depth across equity research, sales, and business operations. Despite the lack of fund management experience in their prior roles, they have proven their ability to execute the stated investment philosophy well.

Investment Philosophy

Carnelian’s investment philosophy is its QGARP (Quality Growth at Reasonable Price) approach. The framework seeks to identify high-quality businesses with strong cash flows, clean governance, and sustainable moats, while ensuring valuations are reasonable relative to growth prospects. Their research process integrates thematic foresight, bottom-up stock picking, and a proprietary forensic filter called CLEAR—used to evaluate cash flows, liabilities, earnings quality, and corporate governance. Growth is captured through two lenses: “Magic” stocks that are entering accelerated earnings phases due to inflection points like capex completion or leadership change, and “Compounders” that deliver stable, long-duration returns.

PMS Background

Carnelian Capital PMS is a relatively young portfolio management firm founded by Vikas Khemani, Sachin Jain, Manoj Bahety, and Swati Khemani, all of whom were part of the senior management team at Edelweiss prior to setting up Carnelian. The founding team brings strong institutional equity research and capital markets experience. However, as a PMS platform, the translation of this institutional equities pedigree into a long-term fund management track record continues to be established.

PMS Investment Philosophy

Carnelian follows a fundamentally driven, bottom-up, long-only, multi-cap and sector-agnostic investment approach. The philosophy is centred on investing in good growth businesses, managed by high-quality management teams, at fair valuations, with a strong emphasis on governance, forensic diligence, and risk–reward balance.

Investment Framework

  • Good Businesses: Companies with robust profitability, cost leadership, large opportunity size, free cash flow generation, strong incremental return on capital, time-tested business models, and sustainable competitive moats.
  • Great Management: Evaluated on integrity, modesty, capability, capital allocation discipline, governance standards, and risk management culture.
  • Favourable Risk–Reward: Investments require clear upside potential supported by margin of safety, assessed across business risk, balance sheet risk, and valuation comfort.
  • Negative Screening: Explicit avoidance of companies with aggressive accounting, high financial leverage, low tax incidence, misaligned management incentives, poor governance history, or management teams perceived to be rushing value creation.

Forensic Diligence – CLEAR Framework

Carnelian employs a rigorous forensic framework known as CLEAR, implemented through a two-step process.

  1. Automated Forensic Screening: A template-driven review of 10 years of historical data to identify potential red flags. Companies failing this stage are rejected outright.
  2. Forensic Deep Dive: Detailed analysis of annual reports and financial statements by the forensic team, presented in a structured format to the Investment Committee.

The CLEAR framework evaluates Cash Flows (sustainability vs reported), Liability Analysis (true vs reported debt and contingencies), Earnings Quality (economic vs reported profits), Asset Quality (core vs non-core assets), and Related Party Transactions & Governance. Any stock failing this framework is rejected by the Investment Committee.

Portfolio Construction – MCO Framework

The portfolio is constructed using Carnelian’s MCO framework— Magic, Compounders, and Opportunistic—allowing flexibility across market cycles.

MAGIC (50–60%)

Investments in companies undergoing acceleration in growth and valuation re-rating, where “magic moments” are yet to be fully recognised by the market.

  • Tracking corporate announcements, promoter and management changes
  • Regular management interactions, channel checks, and industry expert calls
  • Monitoring sharp improvements in revenues, margins, and working capital
  • Identifying inflection points such as end of capex cycles

Magic moments are typically triggered by management changes, shifts in industry structure, new growth catalysts, product innovation, or completion of major capex phases.

COMPOUNDERS (40–50%)

Investments in stable, capital-efficient businesses capable of delivering smooth, long-term compounding.

  • Structural screeners using 10 years of historical data on revenues, EPS CAGR, ROE, cash flow conversion, and leverage
  • Preference for non-cyclical, non-commoditised businesses with limited regulatory risk and operational simplicity

Compounders are identified based on the MRFG framework:

  • Moat – sustainable competitive advantage and large opportunity size
  • ROE – efficient capital allocation
  • Free Cash Flow – robust cash generation across cycles
  • Growth & Governance – consistent growth with strong governance

OPPORTUNISTIC (0–10%)

Selective exposure to special situations such as IPOs, mergers, demergers, open offers, buybacks, delistings, potential takeovers, and deep-value dislocations, while maintaining strict risk–reward discipline.

Risk Management

  • Single stock exposure: Maximum 10%
  • Sector exposure: Maximum 40%
  • Single promoter group exposure: Maximum 20%
  • Liquidity: 70% of the portfolio must be liquidatable within 5 trading sessions
  • Re-evaluation trigger: Any stock underperforming the benchmark by more than 20% requires mandatory reassessment and presentation to the Investment Committee within 7 days.
  • Investment Committee oversight: All fresh buys require IC approval; stocks may be exited if the IC is not satisfied with reassessment outcomes.

Sell Strategy

  • Material change in the investment hypothesis
  • Error identified in the original investment thesis
  • Valuation significantly exceeding fundamental value
  • Availability of superior opportunities with better risk–reward

Trailing Performance

1yr3yr5yrSince Inception
Carnelian Shift-3.529.334.535.2
S&P BSE 5004.914.617.220.8
Alpha over Broad Mkt BM-8.414.717.314.4
Nifty Midcap 1507.52324.6
Alpha over Category BM-116.39.9

Performance as of: 30-Nov-25 | Inception Date: 06-Oct-20 | Performance are post-fees, pre-taxes. Global funds denominated in USD or fund currency.

Investment team

Vikas Khemani | 4-star rated FM

Co-Founder | 30 yrs Experience | 8 yrs at current firm

Past Experience: President (Edelweiss Capital), AVP (ICICI Securities)

Vikas Khemani has over 2 decades of experience of which he spent 17 years incubating and building several businesses to leadership positions including Institutional Equities and Equity Research as a CEO at Edelweiss Securities. He is associated with several industry bodies and committees including the CII National Council on Corporate Governance, FICCI Capital Markets Committee, Executive Council of Bombay Management Association. Vikas Khemani comes with strong business acumen and a deep understanding of the capital markets along with strong relationships with Corporate India.

Manoj Bahety | 4-star rated FM

Co-Founder | 29 yrs Experience | 7 yrs at current firm

Past Experience: Managing Partner (Omniscient Capital Advisors), Deputy Head Research (Edelweiss Securities), Sr. Manager (Morgan Stanley), Manager (Reliance Industries)

Manoj Bahety is a CA and CFA Charter holder with 20 years of rich and diverse financial services with marquee institutions. Manoj spent 11 years at Edelweiss Securities as Dy. Head - Institutional Equity Research, Head - forensic, thematic & mid-cap research. He is known for his "Analysis Beyond Consensus" forensic research approach which helped in avoiding pitfalls and identifying several multi-bagger ideas.

Swati Khemani | 4-star rated FM

Partner | 24 yrs Experience | 7 yrs at current firm

Past Experience: Edelweiss

Swati Khemani one of the Partners at Carnelian AMC. She brings over 13 years of experience in the financial services industry, with her previous stints at Edelweiss and her own venture Newedge Consulting. She is a CA and did her graduations in BCom.

Experience the benefits of working with a 'research-first' investments firm

Free 30-Day Trial

Get complimentary access to the revolutionary IME RMS (direct access to IME's central team insights across 1000's of MFs, PMSs, AIFs & Global funds - a first in the industry).

Additionally, a dedicated private banker will help build your financial plan, investment mandate & undertake a comprehensive portfolio review for free.

IME RMS - Preview

IME Capital Logo

IME Capital is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients.

Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer | © 2021 All rights reserved | ARN No: ARN-182445